デジタルPCR市場 - 世界の産業規模、シェア、動向、機会、予測：タイプ別、コンポーネント別、用途別、エンドユーザー別、地域別、競合別、2020～2030年

デジタルPCRの世界市場は、2024年に8億1,456万米ドルと評価され、予測期間中のCAGRは9.23%で、2030年には13億7,262万米ドルに達すると予測されています。

世界のデジタルPCR（dPCR）市場は、分子診断の進歩や正確な核酸定量へのニーズの高まりによって、大幅な成長を遂げています。デジタルPCR技術は、高感度・高特異性で遺伝物質を検出・定量する強力なツールとして登場し、従来のPCR技術に勝る利点を提供しています。標準曲線を必要とせず、標的DNAまたはRNAの絶対定量が可能であるため、腫瘍学、感染症検出、遺伝子研究などの用途で特に有用です。がんや感染症の有病率の上昇と、正確な診断ツールに対する需要の高まりが、臨床や研究の現場でデジタルPCRが広く採用される要因となっています。ドロップレットベースやチップベースのdPCRプラットフォームなどの技術革新により、スループット、多重化能力、使いやすさが向上し、市場浸透をさらに促進しています。特に、デジタルPCRの低レベルの変異や希少な遺伝子変異を検出する能力は、個別化医療やリキッドバイオプシー用途において不可欠なツールとなっています。ヘルスケアに加え、この技術は食品安全、環境モニタリング、法医学などの分野でも採用されています。

市場促進要因

感染症および慢性疾患の増加

主な市場課題

デジタルPCR機器および消耗品の高コスト

主な市場動向

技術と自動化の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のデジタルPCR市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（ドロップレットデジタルPCR、チップベースデジタルPCR、その他）
  • コンポーネント別（システム、キットおよびアッセイ、試薬および消耗品）
  • 用途別（腫瘍学、感染症、希少疾患、生殖遺伝学、その他）
  • エンドユーザー別（学術研究機関、バイオテクノロジー・製薬企業、病院・クリニック、その他）
  • 地域別
  • 企業別（2024年）
• 市場マップ
  • タイプ別
  • コンポーネント別
  • 用途別
  • エンドユーザー別
  • 地域別

第6章 北米のデジタルPCR市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州のデジタルPCR市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のデジタルPCR市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米のデジタルPCR市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのデジタルPCR市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 競合情勢

• Bio-Rad Laboratories, Inc.
• Fluidigm Corporation
• F. Hoffmann-La Roche AG
• Merck KGaA
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.
• Genetron Holdings Limited
• Naveris, Inc.
• SAGA Diagnostics
• Precigenome LLC

第14章 戦略的提言

第15章 調査会社について・免責事項

Global Digital PCR Market was valued at USD 814.56 million in 2024 and is expected to reach USD 1372.62 million by 2030 with a CAGR of 9.23% during the forecast period. The global digital PCR (dPCR) market is witnessing substantial growth, driven by advancements in molecular diagnostics and the growing need for precise nucleic acid quantification. Digital PCR technology has emerged as a powerful tool for detecting and quantifying genetic material with high sensitivity and specificity, offering advantages over traditional PCR techniques. It allows for absolute quantification of target DNA or RNA without the need for standard curves, making it especially useful in applications such as oncology, infectious disease detection, and genetic research. The rising prevalence of cancer and infectious diseases, along with increasing demand for accurate diagnostic tools, is contributing to the widespread adoption of digital PCR across clinical and research settings. Technological innovations, such as droplet-based and chip-based dPCR platforms, have improved throughput, multiplexing capability, and ease of use, further driving market penetration. In particular, the ability of digital PCR to detect low-level mutations and rare genetic variants makes it an essential tool in personalized medicine and liquid biopsy applications. In addition to healthcare, the technology is also being adopted in fields like food safety, environmental monitoring, and forensic science.

Key Market Drivers

Rising Prevalence of Infectious and Chronic Diseases

The rising prevalence of infectious and chronic diseases is a significant driver of growth in the global digital PCR (dPCR) market. Infectious diseases such as COVID-19, influenza, HIV, tuberculosis, and hepatitis continue to challenge healthcare systems worldwide, highlighting the urgent need for highly sensitive, specific, and rapid diagnostic tools. For instance, according to WHO 2024, noncommunicable diseases (NCDs) caused 43 million deaths in 2021, representing 75% of global non-pandemic deaths. Of these, 18 million were premature deaths under age 70, with 82% occurring in low- and middle-income countries. Cardiovascular diseases led NCD fatalities at 19 million, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes-related deaths exceeding 2 million.

Digital PCR has emerged as a valuable technology in this context, capable of detecting minute quantities of viral or bacterial genetic material with remarkable accuracy. Its ability to quantify low-abundance targets makes it ideal for early detection, monitoring viral load, and tracking disease progression, all of which are critical for timely treatment and containment of infectious outbreaks. Beyond infectious diseases, the global burden of chronic conditions such as cancer, cardiovascular diseases, and genetic disorders is also rising steadily. In oncology, for example, dPCR plays a crucial role in the detection of rare mutations, analysis of circulating tumor DNA (ctDNA), and monitoring of minimal residual disease, supporting the move toward personalized medicine and targeted therapies. As these diseases often require long-term monitoring and precision in diagnosis, the demand for robust molecular diagnostic tools like dPCR continues to grow. The increasing incidence of co-morbidities and aging populations globally is driving the need for diagnostic technologies that offer both accuracy and efficiency. Digital PCR provides an edge by enabling absolute quantification without the need for standard curves, making it highly reliable for clinical decision-making. In regions with limited healthcare infrastructure, dPCR's precision can be particularly valuable in overcoming diagnostic challenges.

Key Market Challenges

High cost of digital PCR instruments and consumables

The high cost of digital PCR (dPCR) instruments and consumables is a significant challenge impacting the growth and accessibility of the global digital PCR market. Digital PCR technology involves sophisticated instrumentation that requires advanced engineering, precise microfluidics, and sensitive detection systems, all of which contribute to the elevated price of these platforms compared to traditional PCR methods. For many laboratories, especially smaller research facilities and those in developing regions, the initial capital investment for purchasing dPCR machines can be prohibitively expensive. This high upfront cost limits the widespread adoption of the technology, despite its clear advantages in sensitivity and accuracy. In addition to the instrument cost, consumables such as reagents, chips, or droplets used in digital PCR assays tend to be more expensive than those used in conventional PCR. These consumables are often proprietary and must be purchased from specific manufacturers, which further drives up operational expenses. The recurring cost of consumables can strain the budgets of clinical laboratories and research institutions, particularly when large sample volumes need to be analyzed regularly. This cost barrier also affects the integration of digital PCR into routine clinical diagnostics, as healthcare providers may be reluctant to adopt expensive technologies without clear reimbursement policies or cost-benefit evidence. In resource-limited settings, the affordability of the technology remains a major concern, slowing the adoption of dPCR where it could significantly improve diagnostic accuracy. Addressing these cost challenges through technological innovation aimed at reducing manufacturing expenses, increasing automation, and promoting competitive pricing is crucial for expanding the digital PCR market. Additionally, developing cost-effective consumable solutions and fostering partnerships to improve affordability will help increase accessibility and adoption globally.

Key Market Trends

Advancement in Technology and Automation

Advancements in technology and automation are key drivers transforming the global digital PCR (dPCR) market. Recent innovations have focused on improving the accuracy, speed, and user-friendliness of dPCR platforms, making them more accessible and efficient for a broader range of applications. Automated systems now integrate sample preparation, partitioning, amplification, and data analysis into streamlined workflows, significantly reducing manual intervention and the potential for human error. This automation enhances reproducibility and throughput, addressing the demand for faster turnaround times in clinical and research laboratories. Technological progress has also led to the development of more sensitive and versatile dPCR platforms, including droplet-based and chip-based systems capable of multiplexing-simultaneously detecting multiple targets within a single sample. These improvements enable more comprehensive genetic analysis and reduce costs by maximizing data output per run.

User-friendly software with advanced algorithms now supports more straightforward data interpretation, enabling laboratories with limited bioinformatics expertise to adopt digital PCR more easily. Additionally, miniaturization and portable dPCR devices are emerging, facilitating point-of-care testing and on-site analysis, which expands the technology's applicability beyond centralized labs. Advancements in technology and automation are not only improving the performance and reliability of digital PCR but are also lowering operational barriers, accelerating adoption, and expanding market reach across healthcare and non-healthcare sectors.

Key Market Players

• Bio-Rad Laboratories, Inc.
• Fluidigm Corporation
• F. Hoffmann-La Roche AG
• Merck KGaA
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.
• Genetron Holdings Limited
• Naveris, Inc.
• SAGA Diagnostics
• Precigenome LLC

Report Scope:

In this report, the Global Digital PCR Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital PCR Market, By Type:

• Droplet Digital PCR
• Chip Based Digital PCR
• Others

Digital PCR Market, By Component:

• Systems
• Kits and Assays
• Reagents and Consumables

Digital PCR Market, By Application:

• Oncology
• Infectious Diseases
• Rare Diseases
• Reproductive Genetics
• Others

Digital PCR Market, By End User:

• Academic and Research Institutions
• Biotechnology & Pharmaceutical Companies
• Hospitals and Clinics
• Others

Digital PCR Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital PCR Market.

Available Customizations:

Global Digital PCR Market report with the given Market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital PCR Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Droplet Digital PCR, Chip Based Digital PCR, Others)
  • 5.2.2. By Component (Systems, Kits and Assays, Reagents and Consumables)
  • 5.2.3. By Application (Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others)
  • 5.2.4. By End User (Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Component
  • 5.3.3. By Application
  • 5.3.4. By End User
  • 5.3.5. By Region

6. North America Digital PCR Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Component
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Digital PCR Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Component
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Digital PCR Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Component
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Digital PCR Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Component
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Digital PCR Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Component
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Digital PCR Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Component
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Digital PCR Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Component
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Digital PCR Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Component
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Digital PCR Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Component
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Digital PCR Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Component
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Digital PCR Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Component
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Digital PCR Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Component
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Digital PCR Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Component
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Digital PCR Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Digital PCR Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Component
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Digital PCR Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Component
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Digital PCR Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Component
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Digital PCR Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Component
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Digital PCR Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Component
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Digital PCR Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Component
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Digital PCR Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Component
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Digital PCR Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Component
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Digital PCR Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Component
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Digital PCR Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Component
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Bio-Rad Laboratories, Inc.
  • 13.1.1. Business Overview
  • 13.1.2. Company Snapshot
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Recent Developments
  • 13.1.6. SWOT Analysis
• 13.2. Fluidigm Corporation
• 13.3. F. Hoffmann-La Roche AG
• 13.4. Merck KGaA
• 13.5. QIAGEN N.V.
• 13.6. Thermo Fisher Scientific Inc.
• 13.7. Genetron Holdings Limited
• 13.8. Naveris, Inc.
• 13.9. SAGA Diagnostics
• 13.10. Precigenome LLC

14. Strategic Recommendations

15. About Us & Disclaimer